These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 2209491

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pregnancy complicated by obsessive-compulsive disorder.
    Chelmow D, Halfin VP.
    J Matern Fetal Med; 1997; 6(1):31-4. PubMed ID: 9029382
    [Abstract] [Full Text] [Related]

  • 23. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [Abstract] [Full Text] [Related]

  • 24. Clomipramine for obsessive-compulsive disorder.
    Feinberg M.
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [Abstract] [Full Text] [Related]

  • 25. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG, Belotto C, Curi M, Hounie AG, Rosário-Campos MC, Diniz JB, Ferrão YA, Pato MT, Miguel EC.
    Compr Psychiatry; 2006 May; 47(4):276-81. PubMed ID: 16769302
    [Abstract] [Full Text] [Related]

  • 26. Obsessive-compulsive disorder.
    George MS.
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [Abstract] [Full Text] [Related]

  • 27. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF, Correa H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.
    Am J Psychiatry; 2005 Jan 01; 162(1):151-61. PubMed ID: 15625214
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.